Cancer Family
Intraepithelial Neoplasia
CI-CAN-00000210Explore in graph →
Non-malignant79 active trials
- NCIt
- C8366
Loading cancer entity…
Cancer Family
CI-CAN-00000210Explore in graph →
Clinical trials
491 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07092007 | NWRD09 for HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer | unknown | N/A | 18 | Newish Technology (Beijing) Co., Ltd.INDUSTRY | 1 | Jul 29, 2025 | clinicaltrials |
| NCT06452004 | Validation of Artificial Intelligence as Decision Support System in VIA (PRESCRIP-TEC)(AI-DSS) | unknown | N/A | 600 | University Medical Center GroningenOTHER | 1 | Apr 4, 2025 | clinicaltrials |
| NCT06741150 | NWRD09 for HPV-16 Positive and HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer Patients. | unknown | N/A | 18 | Newish Technology (Beijing) Co., Ltd.INDUSTRY | 1 | Dec 18, 2024 | clinicaltrials |
| NCT06525870 | Efficacy of Topical 85% TCA in the Treatment of LSIL After Low-grade Abnormality of Screening Test: a Randomized Controlled Trial(Trichlosil) | unknown | Phase 2 | 44 | Department of Medical Services Ministry of Public Health of ThailandOTHER_GOV | 1 | Nov 14, 2024 | clinicaltrials |
| NCT06491888 | A Multicenter Randomized Controlled Study of Photoelectric Detection in Cervical Cancer Screening | unknown | N/A | 4,200 | Lei LiOTHER | 1 | Aug 15, 2024 | clinicaltrials |
| NCT05675787 | Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia | unknown | Phase 2 | 82 | Peking University People's HospitalOTHER | 1 | Jul 11, 2024 | clinicaltrials |
| NCT00892866 | CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells | unknown | N/A | 877 | GOG FoundationNETWORK | 3 | May 3, 2024 | clinicaltrials |
| NCT04895020 | Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years | unknown | Phase 3 | 1,200 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Apr 17, 2024 | clinicaltrials |
| NCT06314113 | Evaluation of Oral EGCG Treatment for L-SIL Associated With HPV Infection(EGCG-HPV) | unknown | — | 50 | University of PalermoOTHER | 1 | Mar 15, 2024 | clinicaltrials |
| NCT06261879 | Non-invasive Biomarker Discovery for Pre-cervical or/and Cervical Cancer--ACTN4 and Other Biomarkers in Menstrual Blood | unknown | N/A | 300 | WomenX Biotech LimitedINDUSTRY | 1 | Feb 15, 2024 | clinicaltrials |
| NCT06208319 | Development and Evaluation of an Artificial Intelligence Tool for Colposcopy Assistance(IACOL) | unknown | — | 1,000 | Assistance Publique - Hôpitaux de ParisOTHER | 0 | Feb 1, 2024 | clinicaltrials |
| NCT02937155 | In the Era of the HPV Vaccine, What Are The Current HPV Subtypes Contributing to High Grade Cervical Dysplasia, Adenocarcinoma in Situ, and Early Cervical Cancer? | unknown | — | 100 | Sunnybrook Health Sciences CentreOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT05051852 | HPV Viral Load in Predicting the Prognosis of LSIL | unknown | — | 1,000 | Fujian Maternity and Child Health HospitalOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT05282745 | A Multicenter Cohort Study of HPV Viral Load in Predicting the Postoperative Recurrence of HSIL | unknown | — | 4,000 | Fujian Maternity and Child Health HospitalOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT05283239 | Research About Impact of HPV Integration on the Prognosis of Women With Persistent HR-HPV Infection | unknown | — | 1,000 | Fujian Maternity and Child Health HospitalOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT05542030 | CAD EYE Detection of Remaining Lesions After EMR | unknown | N/A | 60 | Instituto Ecuatoriano de Enfermedades DigestivasOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT06015854 | Vvax001 Cancer Vaccine in Premalignant Cervical Lesions - Phase II(Vvax) | unknown | Phase 2 | 18 | University Medical Center GroningenOTHER | 1 | Aug 29, 2023 | clinicaltrials |
| NCT05932758 | Excisional Vacuum-Assisted Breast Biopsy | unknown | N/A | 300 | European Institute of OncologyOTHER | 1 | Jul 21, 2023 | clinicaltrials |
| NCT05931354 | Longitudinal HPV Pap in CIN and VAIN(LHPCV) | unknown | — | 600 | Chang Gung Memorial HospitalOTHER | 1 | Jul 5, 2023 | clinicaltrials |
| NCT05868252 | Molecular Analysis of the Sloane Project | unknown | — | 1,500 | King's College LondonOTHER | 1 | May 22, 2023 | clinicaltrials |
| NCT05858021 | COrSIcA: Disease Measurement | unknown | — | 30 | David FinchOTHER | 0 | May 15, 2023 | clinicaltrials |
| NCT05851079 | Accurate Screening and Prevention of Cervical Lesions-- Development of Accurate Screening Methods for Cervical Lesions | unknown | — | 15,000 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 1 | May 9, 2023 | clinicaltrials |
| NCT05835947 | Anal Cancer Risk In Women | unknown | — | 200 | Imperial College LondonOTHER | 1 | Apr 28, 2023 | clinicaltrials |
| NCT05835960 | Anal Intraepithelial Neoplasia and Anal Squamous Cell Carcinoma | unknown | — | 20 | Imperial College LondonOTHER | 1 | Apr 28, 2023 | clinicaltrials |
| NCT05808816 | "Lactobacillus Crispatus M247, LSIL and Microbiota" | unknown | Phase 4 | 90 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Apr 11, 2023 | clinicaltrials |
| NCT05745597 | Prognostic Study of HPV Virus Integration in Women With HSIL | unknown | — | 1,000 | Fujian Maternity and Child Health HospitalOTHER | 1 | Feb 27, 2023 | clinicaltrials |
| NCT05717634 | Endometrial Changes in Breast Cancer Women. | unknown | — | 829 | Regina Elena Cancer InstituteOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT04704908 | Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (54m) | unknown | — | 979 | Jun ZhangOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT04969445 | The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female | unknown | — | 647 | Jun ZhangOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT05045755 | The Durability of Protection and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female | unknown | — | 1,339 | Jun ZhangOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT05631015 | Artificial Intelligence for Determination of Gastroscopy Surveillance Intervals | unknown | — | 2,000 | Xiuli ZuoOTHER | 1 | Nov 30, 2022 | clinicaltrials |
| NCT03049553 | Trial23 - A Method Study on Cervical Screening in Women Offered HPV-vaccination as Girls | unknown | N/A | 7,000 | University of CopenhagenOTHER | 1 | Nov 4, 2022 | clinicaltrials |
| NCT05580341 | Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9 | unknown | Phase 3 | 1,200 | Shanghai Zerun Biotechnology Co.,LtdINDUSTRY | 1 | Oct 28, 2022 | clinicaltrials |
| NCT05595252 | Retrospective Study on the Evolution of CIN 1 to 3 in Per and Postpartum in Nancy From 2014 to 2022 | unknown | — | 100 | Central Hospital, Nancy, FranceOTHER | 1 | Oct 26, 2022 | clinicaltrials |
| NCT05536843 | Clinical, Translational and Biomarker-Based Female Genital HPV Induced Dysplasia and Cancer Screening Study Using Cf-HPV-DNA Blood Tests(TTMV HPV DNA) | unknown | — | 500 | University of Mississippi Medical CenterOTHER | 0 | Sep 13, 2022 | clinicaltrials |
| NCT05142397 | The Dynamic Process of VMB and Mucosal Immunity After FUS Treatment of CIN Patients With Fertility Requirement | unknown | — | 90 | Shufang ChangOTHER | 1 | Aug 18, 2022 | clinicaltrials |
| NCT04484415 | Efficacy and Safety of Cevira® in Patients With Cervical Histologic High-grade Squamous Intraepithelial Lesions (HSIL)(APRICITY) | unknown | Phase 3 | 402 | Asieris MediTech (Hong Kong) Co., Ltd.INDUSTRY | 1 | Aug 12, 2022 | clinicaltrials |
| NCT03947775 | HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL | unknown | Phase 2 | 228 | University Health Network, TorontoOTHER | 1 | Jun 13, 2022 | clinicaltrials |
| NCT04742543 | Virtual Reality During Conization of Cervix Uterus Under Local Anesthesia | unknown | N/A | 100 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Jun 2, 2022 | clinicaltrials |
| NCT05309122 | Cervical Cancer Screening Strategies | unknown | — | 10,000 | Lei LiOTHER | 1 | Apr 4, 2022 | clinicaltrials |
| NCT03113942 | Study of Pomalidomide in Anal Cancer Precursors(SPACE) | unknown | Phase 2 | 26 | Kirby InstituteOTHER_GOV | 1 | Mar 31, 2022 | clinicaltrials |
| NCT05290428 | DNA PAX1 and JAM3 Methylation for Cervical Cancer Screening | unknown | — | 459 | Peking Union Medical College HospitalOTHER | 1 | Mar 22, 2022 | clinicaltrials |
| NCT05225493 | HIV Indicator Diseases in Hospital and Primary Care(#AwareHIV) | unknown | — | 1,500 | Erasmus Medical CenterOTHER | 1 | Feb 4, 2022 | clinicaltrials |
| NCT05210348 | Clinical Evaluation of Detection of High Risk HPV in Urine(Urine-hrHPV) | unknown | — | 1,000 | Peking University People's HospitalOTHER | 1 | Jan 27, 2022 | clinicaltrials |
| NCT04109573 | Function Following Laser for Anal Intraepithelial Neoplasia (FLAN)(FLAN) | unknown | N/A | 20 | Homerton University Hospital NHS Foundation TrustOTHER | 1 | Aug 31, 2021 | clinicaltrials |
| NCT03321461 | TMTP1-ICG Mapping in Colposcopy-directed Biopsy | unknown | Phase 1 | 40 | Huazhong University of Science and TechnologyOTHER | 1 | Jun 30, 2021 | clinicaltrials |
| NCT04859361 | Comparison of Treatment of Cervical Intraepithelial Lesions With Imiquimod or LLETZ | unknown | N/A | 104 | University Medical Centre MariborOTHER | 1 | May 3, 2021 | clinicaltrials |
| NCT04843397 | Diagnostic Performance Indicators in Upper GI Endoscopy:PROSPERO Study(PROSPERO) | unknown | — | 1,000 | University of CambridgeOTHER | 0 | Apr 15, 2021 | clinicaltrials |
| NCT04783649 | Clinical Validation of Cervical Cancer Screening Methods | unknown | — | 2,500 | N.N. Petrov National Medical Research Center of OncologyOTHER | 1 | Mar 5, 2021 | clinicaltrials |
Data updated 22 days agoSource updated Jul 29, 2025source: clinicaltrials